HCM
IMGN

Highbridge Capital Management’s Immunogen Inc IMGN Stock Holding History

Highbridge Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-57,200
Closed -$437K – 2044
2017
Q3 		$437K Buy
+57,200
New +$380K 0.01% 1009
2016
Q2 		– Sell
-15,400
Closed -$132K – 1822
2016
Q1 		$132K Buy
+15,400
New +$130K ﹤0.01% 1389

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Highbridge Capital Management's IMGN Position: Q1 2024 in Review

Highbridge Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 200,000 shares — an estimated $5.93M sold.

Highbridge Capital Management first reported a position in IMGN in Q2 2014 and held it in 4 quarters. The position peaked at $5.93M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Highbridge Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Highbridge Capital Management sold 200,000 Immunogen Inc shares in Q1 2024, an estimated $5.93M.
  • Highbridge Capital Management first reported a position in Immunogen Inc in Q2 2014 and held it in 4 quarters.
  • Highbridge Capital Management's Immunogen Inc position peaked at $5.93M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Highbridge Capital Management's 13F filing for Q1 2024, filed 10 May 2024.